Thrombophilia surgery: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
Line 11: Line 11:
**Contraindications to or complications from [[anticoagulation]]
**Contraindications to or complications from [[anticoagulation]]
**Recurrent thrombosis on anticoagulation, or failure to acheive therapeutic anticoagulation levels
**Recurrent thrombosis on anticoagulation, or failure to acheive therapeutic anticoagulation levels
*Patients with inherited thrombophilia who undergo surgery should generally be treated as a high-risk group and receive prophylactic periperative anticoagulation with LMWH. **Antithrombin deficiency: Surgery is associated with a reduction in antithrombin levels for 3–5 days postoperatively and some patients with antithrombin deficiency and low concentrations of antithrombin may not respond well to heparin. For this reason and to reduce the risk of bleeding from anticoagulation, antithrombin concentrate has been used successfully in several case reports and studies.


==References==
==References==

Revision as of 19:00, 20 February 2021

Thrombophilia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thrombophilia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thrombophilia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thrombophilia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thrombophilia surgery

CDC on Thrombophilia surgery

Thrombophilia surgery in the news

Blogs on Thrombophilia surgery

Directions to Hospitals Treating Thrombophilia

Risk calculators and risk factors for Thrombophilia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Asiri Ediriwickrema, M.D., M.H.S. [2]

Overview

Surgery is not required for treatment for thrombophilia. IVC filter placement may be indicated if the patient has contraindications to or complications from anticoagulation, recurrent thrombosis on anticoagulation, or failure to acheive therapeutic anticoagulation levels.[1]

Surgery

  • Surgery is not required for treatment for thrombophilia
  • IVC filter placement may be indicated in certain scenarios:
    • Contraindications to or complications from anticoagulation
    • Recurrent thrombosis on anticoagulation, or failure to acheive therapeutic anticoagulation levels
  • Patients with inherited thrombophilia who undergo surgery should generally be treated as a high-risk group and receive prophylactic periperative anticoagulation with LMWH. **Antithrombin deficiency: Surgery is associated with a reduction in antithrombin levels for 3–5 days postoperatively and some patients with antithrombin deficiency and low concentrations of antithrombin may not respond well to heparin. For this reason and to reduce the risk of bleeding from anticoagulation, antithrombin concentrate has been used successfully in several case reports and studies.

References

  1. Inferior Vena Cava Filters. Medscape (2015). URL Accessed on July 17, 2016

Template:WH Template:WS